Journal of Clinical Oncology, Vol 6, 34-43, Copyright © 1988 by American Society of Clinical Oncology
Acute lymphoid leukemia in adolescents: clinical and biologic features predict a poor prognosis--a Pediatric Oncology Group Study
W Crist, J Pullen, J Boyett, J Falletta, J van Eys, M Borowitz, J Jackson, B Dowell, C Russell and F Quddus
St. Jude Children's Research Hospital, Memphis.
Analysis of remission induction rates for 1,768 children (1.5 to 11 years)
and 425 adolescents (greater than or equal to 11 years) with acute lymphoid
leukemia (ALL), and of event-free survival times for 570 children and 147
adolescents, disclosed that adolescents fared significantly worse by both
measures of treatment outcome (P = .0001). Adolescents with either T cell
or non-T cell ALL entered remission significantly less often than did
children (P = less than .02 and P = less than .001, respectively). Within
each of the major immunophenotypes of ALL, adolescents had shorter duration
of continuous complete remission: early pre-B (non-B, non pre-B, non-T) (P
= .001), pre-B (P = .05), and T (P = .027). We compared the clinical
characteristics of adolescents and children, and lymphoblast
characteristics present at diagnosis to account for the inferior prognosis
of adolescent patients. Adolescents had a higher incidence of T cell ALL (P
= .0001) and thus a higher incidence of all T cell- associated
characteristics. Adolescents with non-T, non-B ALL were more likely to be
male (P = .044), and to have higher leukocyte counts (P = .002) and lower
levels of IgG (P = .0003), IgA (P = .0001), and IgM (P = .002). Their
leukemic cells had lower PAS scores (P = .0001), a higher incidence rate of
L2 morphology by French-American-British (FAB) criteria (P = .001), common
ALL antigen negativity (P = .0001), and hypodiploid or pseudodiploid
karyotypes (P = .004). These findings clearly indicate an increased
incidence of prognostically unfavorable clinical and biologic features in
adolescents with ALL, providing a biologic explanation for their poor
prognosis.